Accelerated Phase Chronic Myelogenous Leukemia Withdrawn Phase 2 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0028985 (Accelerated Phase Chronic Myelogenous Leukemia)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01652014Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesTreatment